University Medical Center Groningen

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1614-01-01

Employees: 10K

Market Cap: -

Website: https://www.umcg.nl

Clinical Trials

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients

Completed

Conditions: Chronic Kidney Diseases
SARS-CoV Infection
Covid19

Interventions: Diagnostic Test: mailer-based finger-prick

First Posted Date: 2021-04-12

Last Posted Date: 2024-03-18

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 4868

Registration Number: NCT04841785

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study

Completed

Conditions: Covid19
Chronic Kidney Diseases

Interventions: Biological: SARS-CoV-2 vaccination

First Posted Date: 2021-02-05

Last Posted Date: 2022-04-04

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 854

Registration Number: NCT04741386

Locations: 🇳🇱
Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇳🇱
Radboud university medical center, Nijmegen, Gelderland, Netherlands

and more 1 locations

Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment

Phase 1

Active, not recruiting

Conditions: Ovarian Cancer

Interventions: Biological: DCP-001

First Posted Date: 2021-02-04

Last Posted Date: 2024-06-17

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 17

Registration Number: NCT04739527

Locations: 🇳🇱
UMCG, Groningen, Netherlands

Assessing the DIAphragM Before ANd After Endobronchial Valve Treatment

Completed

Conditions: Emphysema

Interventions: Diagnostic Test: Echography

First Posted Date: 2021-02-03

Last Posted Date: 2024-02-15

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 25

Registration Number: NCT04735731

Locations: 🇳🇱
UMCG Groningen, Groningen, Netherlands

Bioequivalence Study of Prednisolone and Dexamethasone

Phase 1

Conditions: Healthy Volunteers

Interventions: Drug: Prednisolone
Drug: Dexamethasone

First Posted Date: 2021-02-01

Last Posted Date: 2022-04-12

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 24

Registration Number: NCT04733144

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules

Not Applicable

Conditions: Thyroid Nodule

Interventions: Device: MSOT Acuity Echo

First Posted Date: 2021-01-29

Last Posted Date: 2021-01-29

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 50

Registration Number: NCT04730726

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

Vaccination Against COVID-19 in Cancer

Not Applicable

Active, not recruiting

Conditions: Cancer

Interventions: Biological: mRNA-1273 SARS-CoV-2 vaccine from Moderna

First Posted Date: 2021-01-20

Last Posted Date: 2024-05-03

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 791

Registration Number: NCT04715438

Locations: 🇳🇱
NKI-AvL, Amsterdam, Netherlands
🇳🇱
UMCG, Groningen, Netherlands
🇳🇱
Erasmus MC, Rotterdam, Netherlands

LAG3 PET Imaging in Advanced Solid Tumors

Phase 1

Active, not recruiting

Conditions: Metastatic Solid Tumor

Interventions: Other: 89Zr-DFO-REGN3767
Drug: Cemiplimab

First Posted Date: 2021-01-13

Last Posted Date: 2024-05-03

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 41

Registration Number: NCT04706715

Locations: 🇳🇱
University Medical Center Groninen, Groningen, Netherlands

Dietary Intervention Trial Targeting Metabolic Syndrome After Kidney Transplantation

Not Applicable

Conditions: Kidney Transplant; Complications

Interventions: Other: Dutch Nutritional Guidelines
Other: high-protein, carbohydrate-reduced diet

First Posted Date: 2021-01-06

Last Posted Date: 2021-01-06

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 30

Registration Number: NCT04698408

Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study

Phase 1

Completed

Conditions: Covid19

Interventions: Biological: AKS-452

First Posted Date: 2020-12-23

Last Posted Date: 2024-04-16

Lead Sponsor: University Medical Center Groningen

Target Recruit Count: 112

Registration Number: NCT04681092

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy